2026 Volume 73 Issue 3.4 Pages 462-466
Aim:To explore the clinical features and potential relevance of hypothalamic–pituitary dysfunction in patients with severe motor and intellectual disabilities (SMID). Methods:We retrospectively reviewed 15 residents with SMID (9 males, 6 females;median age 36 years) who were suspected of hypothalamic or pituitary dysfunction based on recurrent hypothermia, bradycardia, paralytic ileus, vomiting, or stress intolerance. Basal endocrine profiles were evaluated, and cases with hormonal findings suggestive of central endocrine dysfunction were assessed for clinical response to hormone replacement therapy. Because dynamic endocrine testing is often infeasible in this population, the analysis focused on basal hormone levels, characteristic clinical features, and treatment responses. Results:Six patients (40%) showed hormonal findings suggestive of central endocrine dysfunction, including possible central adrenal insufficiency and/or central hypothyroidism. Other pituitary hormones were within reference ranges;however, comprehensive endocrine evaluation was not performed, and broader hypothalamic–pituitary involvement cannot be excluded. Four patients received hormone replacement therapy. Detailed longitudinal treatment-response assessment was available in three patients, in whom clinical improvement was observed. Conclusion:Our findings suggest that some patients with SMID and unexplained systemic instability may exhibit clinical and biochemical features compatible with possible hypothalamic–pituitary dysfunction. These findings should be regarded as hypothesis-generating. J. Med. Invest. 73 : 462-466, August, 2026